Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-07

Clinical Trial Update: Evaluation of Fenugreek Seed Extract In Type- 2 Diabetes: An Add-On Study [Phase 4]

View source ↗

Summary

This document reports the completion status of a Phase 4 add-on trial evaluating fenugreek seed extract in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenugreek seed extract (Trigonella foenum-graecum seed extract)

Snippet

Sponsor: Chemical Resources | Conditions: Diabetes | Phase 4 | Status: COMPLETED